OpenFilings

Scinai Immunotherapeutics Ltd.

Form10-K

Report Period2022-12-31

Date Filed2023-04-17

Time Filed16:06:18

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

ANNUAL REPORT
ARTICLES OF ASSOCIATION OF BIONDVAX PHARMACEUTICALS LTD
DESCRIPTION OF SECURITIES
ADDENDUM TO EMPLOYMENT AGREEMENT DATED MAY 28, 2015, BETWEEN BIONDVAX PHARMACEUT
ADDENDUM TO EMPLOYMENT AGREEMENT DATED APRIL 1, 2012, BETWEEN BIONDVAX PHARMACEU
EMPLOYMENT AGREEMENT DATED SEPTEMBER 5, 2018, BETWEEN BIONDVAX PHARMACEUTICALS L
AMENDMENT AGREEMENT DATED AUGUST 9, 2022, TO FINANCE CONTRACT DATED JUNE 19, 201
CODE OF CONDUCT
CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M
CERTIFICATION
CERTIFICATION
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar